Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
ARHGEF1 deficiency reveals Gα13-associated GPCRs are critical regulators of human lymphocyte function
Divij Mathew, … , Kimberly N. Kremer, Raul M. Torres
Divij Mathew, … , Kimberly N. Kremer, Raul M. Torres
Published February 4, 2019
Citation Information: J Clin Invest. 2019;129(3):965-968. https://doi.org/10.1172/JCI125893.
View: Text | PDF
Commentary

ARHGEF1 deficiency reveals Gα13-associated GPCRs are critical regulators of human lymphocyte function

  • Text
  • PDF
Abstract

Primary antibody deficiencies are the most common immunodeficiencies in humans; however, identification of the underlying genetic and biochemical basis for these diseases is often difficult, given that these deficiencies typically involve complex genetic etiologies. In this issue of the JCI, Bouafia et al. performed whole-exome sequencing on a pair of siblings with primary antibody deficiencies and identified genetic mutations that result in a deficiency of ARHGEF1, a hematopoietic intracellular signaling molecule that transmits signals from GPCRs. ARHGEF1-deficient lymphocytes from the affected siblings exhibited important functional deficits that indicate that loss of ARHGEF1 accounts for the observed primary antibody deficiency, which manifests in an inability to mount antibody responses to vaccines and pathogens. Thus, this report demonstrates an important role for ARHGEF1 in GPCR signal transduction required for appropriate adaptive immune responses in humans.

Authors

Divij Mathew, Kimberly N. Kremer, Raul M. Torres

×

Figure 1

ARHGEF1 is an intracellular signaling effector that activates RhoA in response to Gα12/13-associated GPCR signaling.

Options: View larger image (or click on image) Download as PowerPoint
ARHGEF1 is an intracellular signaling effector that activates RhoA in re...
(A) ARHGEF1 RGS activity terminates Gα12/13-associated GPCR signaling and stimulates ARHGEF1 RhoA GEF activity. Active GTP-bound RhoA controls actin cytoskeleton and is required for appropriate integrin adhesion and migration. (B) ARHGEF1-deficient lymphocytes would not efficiently terminate GPCR signaling nor activate RhoA, resulting in impaired Gα12/13-associated GPCR signaling through S1P, chemokine, and LPA GPCRs. As a result, ARHGEF1-deficient lymphocytes display impaired adhesion and trafficking, ultimately leading to aberrant localization in SLOs and germinal centers and defective antigen-specific antibody responses.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts